Stone House Investment Management »

Abcellera Biologics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $13k 1.7k 7.85

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Total (IXUS)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Eafe Grwth Etf (EFG)
Blackrock Etf Trust Isha I In Te Etf (BAI)
Fidelity Covington Trust Enhanced Intl (FENI)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for Stone House Investment Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Bank of America Corporation
Ubs Global Asset Management Americas
Arrowpoint Asset Management
BlackRock
Susquehanna International
Driehaus Capital Management
Citadel Advisors
Morgan Stanley
UBS Group
Tudor Investment Corporation
Marshall Wace

View all funds holding Abcellera Biologics